BR9607851B1 - combinaÇço e formulaÇço farmacÊutica. - Google Patents

combinaÇço e formulaÇço farmacÊutica.

Info

Publication number: BR9607851B1
Authority: BR; Brazil
Prior art keywords: combination; pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 1995-03-30

Application number

BRPI9607851-0A

Other languages

English (en)

Other versions

BR9607851A (pt

Inventor

David Walter Barry

Clair Martha Heider St

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-30

Filing date

1996-03-28

Publication date

2009-01-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9607851(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-03-30 Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en

1995-03-30 Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en

1996-03-28 Application filed filed Critical

1998-07-21 Publication of BR9607851A publication Critical patent/BR9607851A/pt

2009-01-13 Publication of BR9607851B1 publication Critical patent/BR9607851B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicinal Preparation (AREA)
Cephalosporin Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)

BRPI9607851-0A 1995-03-30 1996-03-28 combinaÇço e formulaÇço farmacÊutica. BR9607851B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9506490.3A GB9506490D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
GBGB9506489.5A GB9506489D0 (en)	1995-03-30	1995-03-30	Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en)	1995-03-30	1996-03-28	Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number	Publication Date
BR9607851A BR9607851A (pt)	1998-07-21
BR9607851B1 true BR9607851B1 (pt)	2009-01-13

Family

ID=26306774

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
BRPI9607851-0A BR9607851B1 (pt)	1995-03-30	1996-03-28	combinaÇço e formulaÇço farmacÊutica.
BRPI9612992-1A BRPI9612992B1 (pt)	1995-03-30	1996-03-28	Combinação, e, formulação farmacêutica
BRPI9607851A BRPI9607851B8 (pt)	1995-03-30	1996-03-28	combinação e formulação farmacêutica.

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
BRPI9612992-1A BRPI9612992B1 (pt)	1995-03-30	1996-03-28	Combinação, e, formulação farmacêutica
BRPI9607851A BRPI9607851B8 (pt)	1995-03-30	1996-03-28	combinação e formulação farmacêutica.

Country Status (35)

Country	Link
US (1)	US6417191B1 (pt)
EP (1)	EP0817637B1 (pt)
JP (1)	JP2954357B2 (pt)
KR (1)	KR100542536B1 (pt)
CN (1)	CN1103593C (pt)
AP (1)	AP652A (pt)
AT (1)	ATE220551T1 (pt)
AU (1)	AU715213B2 (pt)
BR (3)	BR9607851B1 (pt)
CA (1)	CA2216634C (pt)
CZ (1)	CZ295940B6 (pt)
DE (3)	DE69622386T2 (pt)
DK (1)	DK0817637T3 (pt)
EA (1)	EA000626B3 (pt)
EE (1)	EE04047B1 (pt)
ES (1)	ES2179193T3 (pt)
FR (1)	FR05C0022I2 (pt)
GE (1)	GEP20022647B (pt)
HU (1)	HU224010B1 (pt)
IL (1)	IL117727A (pt)
LU (1)	LU91171I2 (pt)
MX (1)	MX9707316A (pt)
MY (1)	MY115461A (pt)
NL (1)	NL300195I2 (pt)
NO (2)	NO313787B1 (pt)
NZ (1)	NZ306419A (pt)
OA (1)	OA10616A (pt)
PL (1)	PL187085B1 (pt)
PT (1)	PT817637E (pt)
RO (1)	RO117995B1 (pt)
SI (1)	SI0817637T1 (pt)
SK (1)	SK283825B6 (pt)
TR (1)	TR199701074T1 (pt)
UA (1)	UA60293C2 (pt)
WO (1)	WO1996030025A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0938321B1 (en) *	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
US6113920A (en) *	1996-10-31	2000-09-05	Glaxo Wellcome Inc.	Pharmaceutical compositions
TW536403B (en) *	1997-03-24	2003-06-11	Glaxo Group Ltd	An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
AU769660B2 (en) *	1997-05-17	2004-01-29	Glaxo Group Limited	Carbocyclic nucleoside hemisulfate and its use in treating viral infections
EP0979082A1 (en) *	1997-05-17	2000-02-16	Glaxo Group Limited	Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
GB9809213D0 (en) *	1998-04-29	1998-07-01	Glaxo Group Ltd	Pharmaceutical compositions
WO1999060988A2 (en) *	1998-05-29	1999-12-02	University Of Florida	Combination therapy for treatment of fiv infection
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US6432966B2 (en)	1999-10-29	2002-08-13	Smithkline Beecham Corporation	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) *	2001-05-11	2011-03-24	Cipla Medpro Pty Ltd	Pharmaceutical composition.
TW200403061A (en) *	2002-06-04	2004-03-01	Glaxo Group Ltd	Pharmaceutical compositions
EA201100293A1 (ru)	2003-01-14	2011-08-30	Джилид Сайэнс, Инк.	Способ (варианты) и фармацевтическая композиция (варианты) для лечения или профилактики симптомов вич-инфекции
WO2004085406A1 (en)	2003-03-24	2004-10-07	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
CA2543490A1 (en)	2003-10-24	2005-05-06	Immunaid Pty Ltd	Method of analysing immune system cycling to monitor and/or treat diseases by the production of regulator t cells
TWI471145B (zh)	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
WO2007045573A1 (en)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
CA2671478C (en)	2006-12-13	2015-02-17	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
CA2677623C (en) *	2007-02-09	2015-04-07	Alphapharm Pty Ltd	A dosage form containing two or more active pharmaceutical ingredients in different physical forms
PT2435825E (pt)	2009-05-27	2015-11-02	Biotempus Ltd	Métodos para o tratamento de doenças
LT3127542T (lt)	2010-01-27	2018-11-26	Viiv Healthcare Company	Antivirusinė terapija
WO2015028875A2 (en)	2013-08-29	2015-03-05	Teva Pharmaceuticals Industries Ltd.	Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
TW201622731A (zh)	2014-04-08	2016-07-01	泰瓦藥品工業有限公司	包含恩曲他濱（Ｅｍｔｒｉｃｉｔａｂｉｎｅ）、替諾福韋（Ｔｅｎｏｆｏｖｉｒ）、地瑞那韋（Ｄａｒｕｎａｖｉｒ）及利托那韋（Ｒｉｔｏｎａｖｉｒ）之單位劑型以及包含地瑞那韋及利托那韋之單層錠劑
CN112430250A (zh)	2014-08-12	2021-03-02	莫纳什大学	定向淋巴的前药
EP3347340A4 (en)	2015-09-08	2019-01-23	Monash University	LYMPHENLEITUNGSPRODRUGS
EP4306524A3 (en) *	2017-08-29	2024-09-11	PureTech LYT, Inc.	Lymphatic system-directing lipid prodrugs
US11883497B2 (en)	2017-08-29	2024-01-30	Puretech Lyt, Inc.	Lymphatic system-directing lipid prodrugs
US11304954B2 (en)	2017-12-19	2022-04-19	Puretech Lyt, Inc.	Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en)	2017-12-19	2023-03-21	Puretech Lyt, Inc.	Lipid prodrugs of rapamycin and its analogs and uses thereof
US20210268115A1 (en)	2020-02-05	2021-09-02	Puretech Lyt, Inc.	Lipid prodrugs of neurosteroids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
US5047407A (en)	1989-02-08	1991-09-10	Iaf Biochem International, Inc.	2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en)	1988-06-10	1992-06-16	Regents Of The University Of Minnesota	Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) *	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
US5204466A (en)	1990-02-01	1993-04-20	Emory University	Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) *	1990-05-02	1990-06-27	Glaxo Group Ltd	Chemical compounds
GB9104740D0 (en) *	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
ATE131730T1 (de)	1991-05-16	1996-01-15	Glaxo Group Ltd	Nukleosidanalogen enthaltende antiviren- zubereitungen
WO1993023021A2 (en) *	1992-05-13	1993-11-25	The Wellcome Foundation Limited	Therapeutic combinations
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en)	1994-08-26	1994-10-19	Wellcome Found	A novel salt
US5869461A (en)	1995-03-16	1999-02-09	Yale University	Reducing toxicity of L-nucleosides with D-nucleosides
CZ429398A3 (cs)	1996-06-25	1999-05-12	Glaxo Group Limited	Kombinace účinných látek a farmaceutický prostředek
EP0938321B1 (en)	1996-06-25	2004-01-14	Glaxo Group Limited	Combinations comprising vx478, zidovudine and 3tc for use in the treatment of hiv
DE10226522A1 (de)	2002-06-14	2003-12-24	Degussa	Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

1996
- 1996-03-27 MY MYPI96001152A patent/MY115461A/en unknown
- 1996-03-28 TR TR97/01074T patent/TR199701074T1/xx unknown
- 1996-03-28 NZ NZ306419A patent/NZ306419A/xx not_active IP Right Cessation
- 1996-03-28 SI SI9630494T patent/SI0817637T1/xx unknown
- 1996-03-28 SK SK1295-97A patent/SK283825B6/sk not_active IP Right Cessation
- 1996-03-28 DE DE69622386T patent/DE69622386T2/de not_active Expired - Lifetime
- 1996-03-28 AU AU54972/96A patent/AU715213B2/en not_active Expired
- 1996-03-28 EA EA199700203A patent/EA000626B3/ru not_active IP Right Cessation
- 1996-03-28 PT PT96911953T patent/PT817637E/pt unknown
- 1996-03-28 GE GEAP19963898A patent/GEP20022647B/en unknown
- 1996-03-28 BR BRPI9607851-0A patent/BR9607851B1/pt active IP Right Grant
- 1996-03-28 AP APAP/P/1997/001089A patent/AP652A/en active
- 1996-03-28 US US08/930,225 patent/US6417191B1/en not_active Expired - Lifetime
- 1996-03-28 RO RO97-01795A patent/RO117995B1/ro unknown
- 1996-03-28 HU HU9801571A patent/HU224010B1/hu active Protection Beyond IP Right Term
- 1996-03-28 AT AT96911953T patent/ATE220551T1/de active
- 1996-03-28 JP JP8528931A patent/JP2954357B2/ja not_active Expired - Lifetime
- 1996-03-28 PL PL96322532A patent/PL187085B1/pl unknown
- 1996-03-28 WO PCT/EP1996/001352 patent/WO1996030025A1/en active IP Right Grant
- 1996-03-28 CN CN96194050A patent/CN1103593C/zh not_active Expired - Lifetime
- 1996-03-28 ES ES96911953T patent/ES2179193T3/es not_active Expired - Lifetime
- 1996-03-28 KR KR1019970706824A patent/KR100542536B1/ko not_active Expired - Lifetime
- 1996-03-28 MX MX9707316A patent/MX9707316A/es active IP Right Grant
- 1996-03-28 EE EE9700240A patent/EE04047B1/xx not_active IP Right Cessation
- 1996-03-28 CA CA002216634A patent/CA2216634C/en not_active Expired - Lifetime
- 1996-03-28 DK DK96911953T patent/DK0817637T3/da active
- 1996-03-28 EP EP96911953A patent/EP0817637B1/en not_active Expired - Lifetime
- 1996-03-28 BR BRPI9612992-1A patent/BRPI9612992B1/pt not_active IP Right Cessation
- 1996-03-28 CZ CZ19973090A patent/CZ295940B6/cs not_active IP Right Cessation
- 1996-03-28 BR BRPI9607851A patent/BRPI9607851B8/pt unknown
- 1996-03-28 DE DE200512000029 patent/DE122005000029I1/de active Pending
- 1996-03-28 DE DE1996622386 patent/DE122005000029I2/de active Active
- 1996-03-28 UA UA97094740A patent/UA60293C2/uk unknown
- 1996-03-29 IL IL11772796A patent/IL117727A/xx not_active IP Right Cessation
1997
- 1997-09-17 OA OA70075A patent/OA10616A/en unknown
- 1997-09-29 NO NO19974510A patent/NO313787B1/no not_active IP Right Cessation
2005
- 2005-05-04 LU LU91171C patent/LU91171I2/fr unknown
- 2005-05-09 NL NL300195C patent/NL300195I2/nl unknown
- 2005-05-09 FR FR05C0022C patent/FR05C0022I2/fr active Active
- 2005-05-24 NO NO2005014C patent/NO2005014I2/no unknown

Also Published As

Publication number	Publication date
KR19980703420A (ko)	1998-11-05
NL300195I2 (nl)	2005-11-01
US6417191B1 (en)	2002-07-09
EP0817637A1 (en)	1998-01-14
PL187085B1 (pl)	2004-05-31
JP2954357B2 (ja)	1999-09-27
NO313787B1 (no)	2002-12-02
EA000626B3 (ru)	2016-04-29
CN1103593C (zh)	2003-03-26
IL117727A0 (en)	1996-07-23
EP0817637B1 (en)	2002-07-17
NO974510L (no)	1997-09-29
BR9607851A (pt)	1998-07-21
CZ309097A3 (cs)	1998-05-13
HUP9801571A2 (hu)	1999-01-28
NO2005014I1 (no)	2005-06-06
BRPI9612992B1 (pt)	2020-08-04
NO974510D0 (no)	1997-09-29
DE69622386D1 (de)	2002-08-22
DK0817637T3 (da)	2002-11-11
AP9701089A0 (en)	1997-10-31
IL117727A (en)	1999-11-30
FR05C0022I1 (pt)	2005-06-10
HU224010B1 (hu)	2005-04-28
EA199700203A1 (ru)	1998-02-26
DE69622386T2 (de)	2003-02-13
HUP9801571A3 (en)	2001-04-28
MY115461A (en)	2003-06-30
DE122005000029I1 (de)	2005-10-06
NO2005014I2 (no)	2008-02-11
BRPI9607851B8 (pt)	2019-11-05
SI0817637T1 (en)	2002-10-31
MX9707316A (es)	1997-11-29
KR100542536B1 (ko)	2006-03-23
FR05C0022I2 (pt)	2005-10-21
UA60293C2 (uk)	2003-10-15
LU91171I2 (fr)	2005-07-04
GEP20022647B (en)	2002-03-25
DE122005000029I2 (de)	2006-04-27
PL322532A1 (en)	1998-02-02
EA000626B1 (ru)	1999-12-29
CA2216634A1 (en)	1996-10-03
RO117995B1 (ro)	2002-12-30
HK1009401A1 (en)	1999-09-10
AU715213B2 (en)	2000-01-20
EE04047B1 (et)	2003-06-16
CZ295940B6 (cs)	2005-12-14
LU91171I9 (pt)	2018-12-28
TR199701074T1 (xx)	1998-02-21
NZ306419A (en)	2000-01-28
PT817637E (pt)	2002-11-29
SK129597A3 (en)	1998-07-08
EE9700240A (et)	1998-04-15
CA2216634C (en)	2004-07-20
AP652A (en)	1998-06-19
OA10616A (en)	2001-03-15
ES2179193T3 (es)	2003-01-16
CN1185110A (zh)	1998-06-17
NL300195I1 (nl)	2005-08-01
AU5497296A (en)	1996-10-16
SK283825B6 (sk)	2004-02-03
WO1996030025A1 (en)	1996-10-03
ATE220551T1 (de)	2002-08-15
JPH10511682A (ja)	1998-11-10

Publication	Publication Date	Title
BR9607851B1 (pt)	2009-01-13	combinaÇço e formulaÇço farmacÊutica.
BR9611367A (pt)	1999-02-23	Formulação farmacêutic liofilizada estável
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
FI973243A0 (fi)	1997-08-06	Uusi farmaseuttinen yhdistelmä
DE69525148D1 (de)	2002-03-14	Pharmazeutische formulierung
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
BR9500784A (pt)	1995-10-24	Composto e formulação farmacêutica
BR9504060A (pt)	1996-09-24	Composto e formulação farmacêutica
DE69618587D1 (de)	2002-02-21	Chinazoline und pharmazeutische zusammensetzungen
NO954486D0 (no)	1995-11-08	Farmasöytiske formuleringsgrunnlag
NO20021172L (no)	1996-12-23	Farmasöytisk sammensetning
DE69513671D1 (de)	2000-01-05	Arzneimittel
NO981008D0 (no)	1998-03-06	Farmasöytisk formulering
BR9602915A (pt)	1998-04-22	Medicamentos uso e formulação farmacêutica
BR9509688A (pt)	1997-09-30	Composto e composição farmacêutica
FI972988L (fi)	1997-09-11	Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
DZ1926A1 (fr)	2002-02-17	Formulations pharmaceutiques.
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
ATE258010T1 (de)	2004-02-15	Pestizide formulierung
FI973280L (fi)	1997-08-08	Farmaseuttinen koostumus
FI973230A0 (fi)	1997-08-05	Uusi farmaseuttinen formulaatio
BR9606066A (pt)	1998-09-01	Composto e formulação farmacêutica
NL1007839A1 (nl)	1998-06-23	Formulering en gebruik.
BR9605131A (pt)	1998-07-07	Composição farmacêutica

Legal Events

Date	Code	Title	Description
2005-06-07	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2007-01-16	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2008-09-02	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2009-02-25	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/02/2009, OBSERVADAS AS CONDICOES LEGAIS.
2013-10-08	B22O	Other matters related to patents and certificates of addition of invention: legal action concerning patent	Free format text: INPI-52400.061560/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132356-33.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: THE SECRETARY OF STATE FOR DEFENCE, THE WELLCOME FOUNDATION LIMITED, THERATECHNOLOGIES INC, UNITED STATES GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY, UNIVERSITE DE MONTREAL.
2019-10-29	B19A	Notification of judicial decision: notification of judicial decision	Free format text: INPI-52400.061560/2013-54 SECAO JUDICIARIA DO RIO DE JANEIRO 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO: NO0132356-33.2013.4.02.5101APELADO: THE SECRETARY OF STATE FOR DEFENCE E OUTROS APELANTE: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI DECISAO: PELO EXPOSTO, DIVIRJO DO EXMO. RELATOR E DOU PROVIMENTO AO RECURSO DE APELACAO E JULGO PROCEDENTE O PEDIDO ALTERNATIVO, PARA DECLARAR A NULIDADE PARCIAL DAS PATENTES PI 9508392-8, PI 9607850-2, PI 9607851-0, PI 9608799-4, PI 9607752-2 E PI 9510423-2, E DETERMINAR A CORRECAO DE SEUS RESPECTIVOS PRAZOS DE VIGENCIA CONFORME TABELA A SEGUIR:PATENTE: PI 9508392-8 NOVO PRAZO DE VIGENCIA: 12/07/2015PATENTE: PI 9607850-2 NOVO PRAZO DE VIGENCIA
2019-11-05	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/02/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A PUBLICACAO NA RPI 1990 DE 25.02.2009, QUANTO AO PRAZO DE VIGENCIA: ATE 28.03.2016, CONFORME DECISAO JUDICIAL PUBLICADA NA RPI 2547 DE 29.10.2019 - INPI 52400.061560/2013